BofA lowered the firm’s price target on Patterson Companies to $31 from $32 and keeps a Buy rating on the shares. Following earnings, the firm is maintaining its FY25 EPS estimate of $2.40 and slightly reducing its FY26 EPS estimate to $2.56, while noting that shares are now trading at levels “representing the lowest levels observed during its 30+ year public history.” While the near-terms headwinds across dental and animal health are “well known,” the stock is “too cheap to keep ignoring,” the firm contends.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDCO:
- Patterson Companies sees FY25 adjusted EPS $2.33-$2.43, consensus $2.39
- Patterson Companies reports Q4 EPS 82c, consensus 82c
- Options Volatility and Implied Earnings Moves Today, June 18, 2024
- Options Volatility and Implied Earnings Moves This Week, June 17 – June 21, 2024
- PDCO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Questions or Comments about the article? Write to editor@tipranks.com